Emerging technologies will be the driving force for the advancement of this world.
BV Baidu Ventures recently announced the completion of the third phase of fund raising, with a total size of 400 million US dollars. After the completion of this round of fundraising, the total size of funds managed by BV has exceeded 700 million U.S. dollars with Baidu Group continuing to fully support it as a funder.
Baidu Ventures was established in 2017 and is an independent venture capital institution initiated by Baidu Group. Baidu Venture Capital focuses on early-stage AI-based technological innovation companies, focusing on several major directions such as technological innovation, life sciences, and business consumption extension. The current investment areas mainly include new energy vehicles, life sciences, corporate services, smart cities, semiconductors, smart industries, and IoT life.
Baidu expressed that it will continue to increase the layout and exploration in the direction of artificial intelligence, and explore the next generation of new technologies and new application scenarios through Baidu Venture Capital.
Baidu Ventures CEO Gao Xue explained that this fund is mainly used to support early-stage hard technology companies, especially in areas that require long-term R&D investment and continuous accumulation to form core original technologies.
We will build a professional investment team that advocates technological innovation. Relying on the doctoral team and industry experts in the field of high-precision technology, it carries out industry research and professional judgment, and grasps the route of technological innovation and development. Gao Xue said.
It is understood that Baidu Venture Capital Fund III has deployed dozens of outstanding start-up companies. In scientific and technological aspect, there are Qingyan Precision, Geometry Partners, and Cun Technology; In medical aspect, there are Tangji Medical Technology, GSI Inda, Jiinga Technology, and ABC Clinic; And in consumer aspect, Daxian Technology, Lefan Health, Gulf Trend, and Bingquan are inclueded.
Metalenz Raises $30 Million Series B Led by Neotribe Ventures to Address Fast Growing Demand for its Breakthrough Metasurface Optics.
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing
BV Family丨SynSense has completed nearly 200 million yuan in Pre-B round of financing
BV Family丨Tiying Media has completed two consecutive rounds of financing, B4 and B5, to promote business model innovation with digitalization.
BV Family丨Defan Information has completed the Series A financing to build a new wave of digitalization of "low code + AI" PaaS platform.
BV Family丨Precision Scientific has completed 150 million yuan in Series B financing, and uses multi-omics data mining to drivenew drug research and development.
BV Family丨Focusing on the Internet of Things SaaS platform services in the commercial concrete industry, Xinzhiwei has completed an angel round of financing of tens of millions of yuan.
BV Family丨 Ruishun Biotechnology has completed 100 million yuan A round of financing to accelerate the development of spot general-purpose DNT cell drugs.
BV Family丨Received investment from Hillhouse Lenovo Baidu, RISC-V startup Ruisichip completes A+ round of financing
First issue丨Baidu's third phase of venture capital fund is completed with 400 million US dollars continuing to invest in emerging technology fields.
BV Family丨Eridi has completed B round of financing and continues to lead the intelligent market for environmental-protection water